Here, we attempted to explore whether Pygo1 participates in abnormal activation of Wnt signaling pathway I in human NSCLC and whether the interaction between Pygo1 and β-catenin affects lung cancer development. This evidence concerns the gene PYGO1 and lung carcinoma.